Items where authors include "Bidlingmaier, M."

Article

Trainer, P.J., Newell-Price, J.D.C., Ayuk, J. et al. (14 more authors) (2018) A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly. European Journal of Endocrinology, 179 (2). pp. 97-108. ISSN 0804-4643

Johannsson, G., Bidlingmaier, M., Biller, B.M.K. et al. (28 more authors) (2018) Growth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocrine Connections, 7 (3). R126-R134. ISSN 2049-3614

Christiansen, J.S., Backeljauw, P., Bidlingmaier, M. et al. (38 more authors) (2016) Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. European Journal of Endocrinology, 174. C1-C8. ISSN 0804-4643

Allen, D.B., Backeljauw, P., Bidlingmaier, M. et al. (37 more authors) (2016) GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 174 (2). P1-P9. ISSN 0804-4643

Bielohuby, M., Zarkesh-Esfahani, S.H., Manolopoulou, J. et al. (9 more authors) (2014) Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits. Disease Models and Mechanisms, 7 (11). pp. 1263-1273. ISSN 1754-8403

Zarkesh-Esfahani, H., Pockley, A.G., Metcalfe, R.A. et al. (6 more authors) (2001) High-Dose Leptin Activates Human Leukocytes Via Receptor Expression on Monocytes. Journal of Immunology, 167 (8). pp. 4593-4599. ISSN 1550-6606